title: Intermittent increases in cytosolic Ca2+ stimulate mitochondrial biogenesis in muscle cells.
abstract: Muscle contractions cause numerous disturbances in intracellular homeostasis. This makes it impossible to use contracting muscle to identify which of the many signals generated by contractions are responsible for stimulating mitochondrial biogenesis. One purpose of this study was to evaluate the usefulness of L6 myotubes, which do not contract, for studying mitochondrial biogenesis. A second purpose was to evaluate further the possibility that increases in cytosolic Ca2+ can stimulate mitochondrial biogenesis. Continuous exposure to 1 microM ionomycin, a Ca2+ ionophore, for 5 days induced an increase in mitochondrial enzymes but also caused a loss of myotubes, as reflected in an approximately 40% decrease in protein per dish. However, intermittent (5 h/day) exposure to ionomycin, or to caffeine or W7, which release Ca2+ from the sarcoplasmic reticulum, did not cause a decrease in protein per dish. Raising cytosolic Ca2+ intermittently with these agents induced significant increases in mitochondrial enzymes. EGTA blocked most of this effect of ionomycin, whereas dantrolene, which blocks Ca2+ release from the sarcoplasmic reticulum, largely prevented the increases in mitochondrial enzymes induced by W7 and caffeine. These findings provide evidence that intermittently raising cytosolic Ca2+ stimulates mitochondrial biogenesis in muscle cells.
authors.affiliation: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: Edward O
authors.initials: EO
authors.lastname: Ojuka
authors.forename: Terry E
authors.initials: TE
authors.lastname: Jones
authors.forename: Dong-Ho
authors.initials: DH
authors.lastname: Han
authors.forename: May
authors.initials: M
authors.lastname: Chen
authors.forename: Brian R
authors.initials: BR
authors.lastname: Wamhoff
authors.forename: Michael
authors.initials: M
authors.lastname: Sturek
authors.forename: John O
authors.initials: JO
authors.lastname: Holloszy
mesh_terms: D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D003574:Cytochrome c Group / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015870:Gene Expression / Q000502:physiology; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000494:pharmacology; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D018485:Muscle Fibers, Skeletal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D019301:Oleic Acid / Q000378:metabolism; D010084:Oxidation-Reduction; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D051381:Rats; D012265:Ribonucleotides / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D003574:Cytochrome c Group; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007476:Ionophores; D010726:Phosphodiesterase Inhibitors; D012265:Ribonucleotides; D013449:Sulfonamides; D019301:Oleic Acid; D000620:Aminoimidazole Carboxamide; D002110:Caffeine; D015759:Ionomycin; C017967:W 7; D000255:Adenosine Triphosphate; D000624:5-Aminolevulinate Synthetase; C031143:AICA ribonucleotide; D002118:Calcium